Jennifer Cannon’s Post

View profile for Jennifer Cannon, graphic

President, Commercial at Thermo Fisher Scientific

We see it in the life science industry, but also in our daily lives – unmet medical needs are growing, making innovation in drug development more crucial than ever. The privilege of working in the life science industry is that we’re right in the mix, developing solutions in real-time that drive speed and efficiency for biopharma and biotech companies aiming to meet those medical needs.  I was pleased to join my Thermo Fisher Scientific colleague Mike Kleppinger, PhD, MBA in providing insights on the latest advancements we’re seeing in this space. Next-gen technologies and collaborative approaches are transforming the partnerships that drive drug development progress. The name of the game is to enable a connected, comprehensive journey – from discovery directly to patient delivery. You can read our full blog, here: https://lnkd.in/erXwD5Uu

Redefining Acceleration of the Drug Development Journey

Redefining Acceleration of the Drug Development Journey

patheon.com

To view or add a comment, sign in

Explore topics